To hear about similar clinical trials, please enter your email below
Trial Title:
An Evaluation of the Implementation of the Care and Monitoring at Home Program- A New Paradigm for Acute Care Management of Cancer Patients
NCT ID:
NCT05904899
Condition:
Cancer
Study type:
Observational
Overall status:
Suspended
Study design:
Time perspective:
Prospective
Summary:
To understand the experience of patients receiving care in the Care and Monitoring at
Home program at MD Anderson. Researchers intend to use this information to study and
possibly improve the hospital care at home program.
Detailed description:
OBJECTIVES
Primary Objectives
The objective of this observational study is to assess the feasibility of providing
hospital substitution hospital level care in the home for patients with cancer through
the CaMH Program. Our primary gauge of feasibility will be a care escalation rate of
<20%, defined as the proportion of patients who initiate care in our HaH program but are
transferred back to the inpatient setting to complete the care episode. This threshold is
consistent with the published literature.15 In addition, a "feasible" designation will
require a median score > 3 on each of three post-discharge survey implementation measures
- the Feasibility of Implementation Measure, Acceptability of Implementation Measure, and
Intervention Appropriateness Measure.
Secondary Objectives
Secondary objectives will include patient experience and perception about CaMH, length of
stay, rate of clinical adverse events during CaMH (falls, pressure ulcers, medication
errors) and 30-days after discharge, 7-day readmission, 30-day readmission, and 30-day
emergency department visit rate. (Note, the aforementioned adverse events could occur as
a result of participation in CaMH. However, minimal adverse events are expected a result
of participation in this observational study (see adverse events below)). A patient will
be considered to have an ER visit or hospital readmission if these events are documented
in the medical record OR the patient reports the event on the survey.
Criteria for eligibility:
Study pop:
Participants enrolled in the Care and Monitoring at Home program at MD Anderson.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Participants will be eligible for enrollment in this study if they have accepted
enrollment in CaMH. No patients will be excluded if they are enrolled in CaMH.
- Cognitively impaired adults will be able to participate in the study if an adults
proxy provides informed consent and completes survey materials on their behalf.
Exclusion Criteria:
- Children and pregnant women will not be enrolled in the CaMH program, and therefore
not eligible for this study.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
MD Anderson Cancer Center
Address:
City:
Houston
Zip:
77030
Country:
United States
Start date:
August 1, 2023
Completion date:
December 31, 2026
Lead sponsor:
Agency:
M.D. Anderson Cancer Center
Agency class:
Other
Source:
M.D. Anderson Cancer Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05904899
http://www.mdanderson.org
